Literature DB >> 18997885

Induction and monitoring of active delayed type hypersensitivity (DTH) in rats.

Christine Beeton1, K George Chandy.   

Abstract

Delayed type hypersensitivity (DTH) is an inflammatory reaction mediated by CCR7- effector memory T lymphocytes that infiltrate the site of injection of an antigen against which the immune system has been primed. The inflammatory reaction is characterized by redness and swelling of the site of antigenic challenge. It is a convenient model to determine the in vivo efficacy of immunosuppressants. Cutaneous DTH can be induced either by adoptive transfer of antigen-specific T lymphocytes or by active immunization with an antigen, and subsequent intradermal challenge with the antigen to induce the inflammatory reaction in a given skin area. DTH responses can be induced to various antigens, for example ovalbumin, tuberculin, tetanus toxoid, or keyhole limpet hemocyanin (KLH).Here we demonstrate how to induce an active DTH reaction in Lewis rats. We will first prepare a water-in-oil emulsion of KLH, our antigen of interest, in complete Freund's adjuvant and inject this emulsion subcutaneously to rats. This will prime the immune system to develop memory T cells directed to KLH. Seven days later we will challenge the rats intradermally on the back with KLH on one side and with ovalbumin, an irrelevant antigen, on the other side. The inflammatory reaction will be visible 16-72 hours later and the red and swollen area will be measured as an indication of DTH severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18997885      PMCID: PMC2557114          DOI: 10.3791/237

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  1 in total

1.  Induction and monitoring of adoptive delayed-type hypersensitivity in rats.

Authors:  Christine Beeton; K George Chandy
Journal:  J Vis Exp       Date:  2007-10-01       Impact factor: 1.355

  1 in total
  8 in total

1.  Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.

Authors:  Zoltan Varga; Georgina Gurrola-Briones; Ferenc Papp; Ricardo C Rodríguez de la Vega; Gustavo Pedraza-Alva; Rajeev B Tajhya; Rezso Gaspar; Luis Cardenas; Yvonne Rosenstein; Christine Beeton; Lourival D Possani; Gyorgy Panyi
Journal:  Mol Pharmacol       Date:  2012-05-23       Impact factor: 4.436

2.  Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.

Authors:  Eric J Tarcha; Victor Chi; Ernesto J Muñoz-Elías; David Bailey; Luz M Londono; Sanjeev K Upadhyay; Kayla Norton; Amy Banks; Indra Tjong; Hai Nguyen; Xueyou Hu; Greg W Ruppert; Scott E Boley; Richard Slauter; James Sams; Brian Knapp; Dustin Kentala; Zachary Hansen; Michael W Pennington; Christine Beeton; K George Chandy; Shawn P Iadonato
Journal:  J Pharmacol Exp Ther       Date:  2012-05-25       Impact factor: 4.030

3.  Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.

Authors:  Mark R Tanner; Rajeev B Tajhya; Redwan Huq; Elizabeth J Gehrmann; Kathia E Rodarte; Mustafa A Atik; Raymond S Norton; Michael W Pennington; Christine Beeton
Journal:  Clin Immunol       Date:  2017-04-04       Impact factor: 3.969

4.  Low-level laser reduces the production of TNF-α, IFN-γ, and IL-10 induced by OVA.

Authors:  Rodrigo G Oliveira; Ana P Ferreira; Andréa J Côrtes; Beatriz J Vieira Aarestrup; Luis C Andrade; Fernando M Aarestrup
Journal:  Lasers Med Sci       Date:  2013-01-22       Impact factor: 3.161

5.  The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.

Authors:  Fang Ye; Youtian Hu; Weiwei Yu; Zili Xie; Jun Hu; Zhijian Cao; Wenxin Li; Yingliang Wu
Journal:  Toxins (Basel)       Date:  2016-04-19       Impact factor: 4.546

6.  Induction and monitoring of adoptive delayed-type hypersensitivity in rats.

Authors:  Christine Beeton; K George Chandy
Journal:  J Vis Exp       Date:  2007-10-01       Impact factor: 1.355

7.  A potent and selective peptide blocker of the Kv1.3 channel: prediction from free-energy simulations and experimental confirmation.

Authors:  M Harunur Rashid; Germano Heinzelmann; Redwan Huq; Rajeev B Tajhya; Shih Chieh Chang; Sandeep Chhabra; Michael W Pennington; Christine Beeton; Raymond S Norton; Serdar Kuyucak
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

8.  Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.

Authors:  Redwan Huq; Errol L G Samuel; William K A Sikkema; Lizanne G Nilewski; Thomas Lee; Mark R Tanner; Fatima S Khan; Paul C Porter; Rajeev B Tajhya; Rutvik S Patel; Taeko Inoue; Robia G Pautler; David B Corry; James M Tour; Christine Beeton
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.